In NSCLC, Ke X and colleagues demonstrated that tumor cells might induce demethylation of the forkhead box P3 (FOXP3) promoter in CD4+ T cells, leading to an increased number and activity of Treg cells. This evidence concerns the gene FOXP3 and neoplasm.